This new report provides analysis of Boehringer Ingelheim’s capabilities, goals and strategies in the global animal health market, including:

- Sales and growth
- Animal health is one of the major pillars
- Swine vaccine Ingelvac circoflex
- Merial animal health
- U.S. animal health market position
- Promoting Eqvalan line
- Seeking to reinforce position in livestock market
- Strategies supported by collaborations
- Merial R&D programs
- Collaborative efforts
- Porcine Reproductive and Respiratory Syndrome (PRRS)
- Decentralized R&D

The report also provides assessment of major U.S. and international trends with potentially significant impact on the animal health industry during the next five years, including discussion of such issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and includes five-year forecasts for:

- Major market segments
- Key geographic regions